Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +0.84% | -3.23% | +14.29% |
03-19 | Aclaris Therapeutics, Inc. Announces Board Resignations | CI |
02-27 | Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 7.76M 621M | Sales 2025 * | 8.69M 695M | Capitalization | 85.52M 6.85B |
---|---|---|---|---|---|
Net income 2024 * | -73M -5.84B | Net income 2025 * | -70M -5.6B | EV / Sales 2024 * | 1.84 x |
Net cash position 2024 * | 71.24M 5.7B | Net cash position 2025 * | 157M 12.6B | EV / Sales 2025 * | -8.28 x |
P/E ratio 2024 * |
-1.23
x | P/E ratio 2025 * |
-1.32
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.23% |
Latest transcript on Aclaris Therapeutics, Inc.
1 day | +0.84% | ||
1 week | -3.23% | ||
Current month | -3.23% | ||
1 month | -4.76% | ||
3 months | -2.44% | ||
6 months | -72.85% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 30/06/12 |
Kevin Balthaser
DFI | Director of Finance/CFO | - | 31/12/16 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 08/08/17 |
Maxine Gowen
BRD | Director/Board Member | 66 | 01/07/19 |
Andrew Powell
BRD | Director/Board Member | 66 | 24/01/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.2 | +0.84% | 445,216 |
25/04/24 | 1.19 | +1.71% | 1,626,758 |
24/04/24 | 1.17 | -4.10% | 1,439,407 |
23/04/24 | 1.22 | 0.00% | 637,744 |
22/04/24 | 1.22 | -1.61% | 663,173 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 85.52M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ACRS Stock